A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

BACKGROUND: To date, no adjuvant treatment has been shown to have a clear benefit in patients with hepatocellular carcinoma (HCC). In this prospective phase I/IIa study, we evaluated the safety and efficacy of adjuvant dendritic cell (DC) therapy in HCC patients who received primary treatment for HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeong-Hoon, Lee, Yoon, Lee, Minjong, Heo, Min Kyu, Song, Jae-Sung, Kim, Ki-Hwan, Lee, Hyunah, Yi, Nam-Joon, Lee, Kwang-Woong, Suh, Kyung-Suk, Bae, Yong-Soo, Kim, Yoon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702003/
https://www.ncbi.nlm.nih.gov/pubmed/26657650
http://dx.doi.org/10.1038/bjc.2015.430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702003/
https://www.ncbi.nlm.nih.gov/pubmed/26657650
http://dx.doi.org/10.1038/bjc.2015.430

Ejemplares similares